D-0888-2023 Class II Terminated
FDA drug recall D-0888-2023 was initiated by Homeocare Laboratories, Inc. on June 5, 2023 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated September 16, 2024). Affected quantity: 40,034/1 fl. oz tubes.
Recall Details
- Product Type
- Drugs
- Report Date
- July 5, 2023
- Initiation Date
- June 5, 2023
- Termination Date
- September 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,034/1 fl. oz tubes
Product Description
StellaLife VEGA Oral Care Spray, 1 fl oz (30 ml) bottles, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-101-02
Reason for Recall
cGMP deviations
Distribution Pattern
Product was distributed USA nationwide.
Code Information
Lot # 2335, exp. date Sep-23; 2364, exp. date Nov-23; 2408, exp. date Feb-24